Jul 07, 2025
Stock exchange release
Inside information, profit warning: Nightingale Health’s revenue increases, and adjusted EBITDA declines compared to the previous financial year
Jul 02, 2025
Jun 16, 2025
Stock exchange release
Nightingale Health strengthens its commercial operations with new EMEA appointment
Jun 13, 2025
Press releases
Nightingale Health’s management team members Minja Salmio and Satu Saksman recognized for outstanding leadership
Jun 12, 2025
Stock exchange release
Nightingale Health’s Board of Directors resolved on new stock option program
Jun 09, 2025
Stock exchange release
Conversion of Nightingale Health Plc’s Series A shares to Series B shares
Apr 23, 2025
Apr 10, 2025
Stock exchange release
Trading in Nightingale Health's B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US
Mar 21, 2025
Stock exchange release
Nightingale Health Plc's listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 2025
Mar 18, 2025
Stock exchange release
The Finnish Financial Supervisory Authority has approved Nightingale Health Plc's Finnish prospectus
Mar 17, 2025
Stock exchange release
Nightingale Health establishes ADR program in the US - trading in Company's B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US
Mar 17, 2025
Stock exchange release
Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki
Mar 12, 2025